Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

Lynn A Bristol

Overview Structured Data Issues Contributors Activity

All edits

Edits on 14 Dec, 2021

"Remove inverse infobox"

edited on 14 Dec, 2021

Edits made to:

Infobox (-7 properties)

Infobox

Patent primary examiner of

US Patent 11174306 Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

US Patent 11180564 IL-17 Receptor A antigen binding proteins

US Patent 11180568 Antibody therapeutics that bind CD137

US Patent 11185586 Allogeneic tumor cell vaccine

US Patent 11186637 Anti-PD1 antibodies and their use as therapeutics and diagnostics

US Patent 11186644 Anti-neuropilin antigen-binding proteins and methods of use thereof

US Patent 7615216 Antibodies against CCR5 and uses thereof

Edits on 3 Dec, 2021

edited on 3 Dec, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Patent primary examiner of

US Patent 7615216 Antibodies against CCR5 and uses thereof

Edits on 2 Dec, 2021

edited on 2 Dec, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Patent primary examiner of

US Patent 11186644 Anti-neuropilin antigen-binding proteins and methods of use thereof

edited on 2 Dec, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Patent primary examiner of

US Patent 11186637 Anti-PD1 antibodies and their use as therapeutics and diagnostics

edited on 2 Dec, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Patent primary examiner of

US Patent 11185586 Allogeneic tumor cell vaccine

Edits on 25 Nov, 2021

edited on 25 Nov, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Patent primary examiner of

US Patent 11180568 Antibody therapeutics that bind CD137

edited on 25 Nov, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Patent primary examiner of

US Patent 11180564 IL-17 Receptor A antigen binding proteins

Edits on 19 Nov, 2021

edited on 19 Nov, 2021

Edits made to:

Infobox (+1 properties)

Infobox

Patent primary examiner of

US Patent 11174306 Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof

"Created via: Entity Importer"

created this topic on 19 Nov, 2021

Edits made to:

Infobox (+2 properties)

‌

Lynn A Bristol

Infobox

Is a

Current Employer

United States Patent and Trademark Office

Find more people like Lynn A Bristol

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.

Open Query Tool

Golden Query Tool